Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
暂无分享,去创建一个
S. Richard | A. Gaudric | P. David | J. Correas | D. Joly | S. Oudard | P. Hammel | S. Deveaux | F. Benoudiba | M. Timsit | A. Méjean | R. Elaidi | G. Benoît | M. Brizard | C. C. Rest | Valérie Caillet | V. Caillet | C. L. Rest